Home
About
FAQ
History (1)
Targeting PCSK9 for therapeutic gains.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting PCSK9 for therapeutic gains.
Shapiro MD, Fazio S, Tavori H. Targeting PCSK9 for therapeutic gains. Curr Atheroscler Rep. 2015 Apr; 17(4):499.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Anticholesteremic Agents
Cholesterol, LDL
Dyslipidemias
Humans
Hypercholesterolemia
Proprotein Convertases
Serine Endopeptidases
authors with profiles
Michael D. Shapiro DO